Companies

Centessa Pharmaceuticals plc

CNTA · CIK 0001847903 · operating

$26.02-1.83%Last updated Mar 3, 4:50 PM

Key Statistics

Valuation

Market Cap$3.81B
P/E
Fwd P/E-15.88
PEG
P/S254.27
P/B11.64
EV/EBITDA-16.10
EV/Rev229.08

Profitability

Gross Margin
Op. Margin
Net Margin
ROE-58.71%
ROA-40.87%
FCF Margin

Financial Health

Current Ratio9.25
Debt/Equity0.44
Free Cash Flow-$142.09M
Div. Yield

Growth & Other

Revenue Growth-100.00%
EPS Growth-31.21%
Beta1.55
52W High$30.58
52W Low$9.6

About Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plc (CNTA) is a pharmaceutical preparations company incorporated in United Kingdom, listed on the Nasdaq. With a market capitalization of $3.9 billion, Centessa Pharmaceuticals plc is a mid-cap company. The stock currently trades at $26.02, down 1.83% today, with a 52-week range of $9.60–$30.58.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-2.06$-2.06-31.2%
2023$-1.57$-1.57+32.0%
2022$-2.31$-2.31+54.4%
2021$-5.07$-5.07

Annual Reports (10-K) · 4 filings

Report DateFiledAccession Number
2024-12-312025-03-240001847903-25-000051SEC ↗
2023-12-312024-03-280001847903-24-000054SEC ↗
2022-12-312023-03-300001847903-23-000063SEC ↗
2021-12-312022-03-300001847903-22-000022SEC ↗